Servier Hellas is an international independent pharmaceutical company specializing in the research and development of treatments for cardiovascular diseases, cancers, diabetes, immune-inflammatory diseases, and neuro-psychiatric disorders. With a strong commitment to innovation and patient care, Servier Hellas is dedicated to providing new options for treatment in these therapeutic areas. Servier Hellas is part of the global Servier Group, which is known for its expertise and extensive research in the field of healthcare.

Their Research and Development Institute in Paris-Saclay is at the forefront of innovation, fostering partnerships and collaborations with both public and private research institutions. In addition to their scientific endeavors, Servier Hellas is also committed to environmental sustainability. They strive to reduce their carbon footprint and promote eco-conscious practices throughout the pharmaceutical lifecycle.

If you are looking for a pharmaceutical brand that combines cutting-edge research with a focus on patient well-being and environmental responsibility, Servier Hellas is the brand for you